Evercyte GmbH
| Knowledge Source Identification | |
|---|---|
| Knowledge source name | Evercyte GmbH |
| Owner/Developer | Evercyte GmbH |
| Country | Austria |
| Languages | English |
| URL | http://www.evercyte.com/ |
| Contact email | office@evercyte.com |
| Description | Evercyte establishes immortalized cell lines that retain key functionalities of the corresponding primary cells and has put a focus on the development of patient specific human iPS cell lines from urine-derived cells, which can be differentiated into any cell of the three germ layers. Evercyte’s cell cultures find their applications as model systems in basic research as well as in pharmaceutical, chemical and cosmetic industries as well as in ecotoxicology. In close collaboration with our clients we also develop novel cell lines from human tissues and establish innovative in vitro test systems to answer our clients’ specific questions. |
| Knowledge Source Category | |
| Category | Organization |
| Sub categories | Biotech Company, R&D Company, Services |
| Knowledge Dissemination and Sharing | |
| Dissemination channel | Website |
| Targeted audience (specified/objective analysis) | Scientists, Industry, Researchers |
| Users access | Open access |
| Knowledge Characterization | |
| 3Rs relevance | Replacement, Reduction |
| Purpose | Fundamental studies, Toxicological and safety evaluation, Method development |
| Technology/Tools | Alternative test methods (in vitro), Stem cells |